EICHORCondition: Alzheimer's Disease · Sponsor: Eli Lilly and Company
The reason for this study is to collect safety and efficacy information regarding the study drug remternetug in participants with early symptomatic Alzheimer's disease (AD).
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| MD First Research - Chandler | Chandler, Arizona, United States | — |
| Hope Clinical Research, Inc. | Canoga Park, California, United States | — |
| North County Neurology Associates | Carlsbad, California, United States | — |
| Wr- Pri, Llc | Encino, California, United States | — |
| Neuro-Pain Medical Center | Fresno, California, United States | — |
| Irvine Clinical Research | Irvine, California, United States | — |
| Kaizen Brain Center | La Jolla, California, United States | — |
| Anderson Clinical Research | Redlands, California, United States | — |
| Mountain Neurological Research Center | Basalt, Colorado, United States | — |
| Alpine Clinical Research Center | Boulder, Colorado, United States | — |
| Colorado Springs Neurological Associates | Colorado Springs, Colorado, United States | — |
| Institute for Neurodegenerative Disorders | New Haven, Connecticut, United States | — |
+ 64 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05463731